Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 Diabetes
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia.
The aim of this trial is to evaluate the blood glucose achieved with insulin detemir as
add-on to current oral antidiabetic drug (OAD) treatment in subjects with type 2 diabetes.